LOL
The history is very ironic and gives insight into the present
Looks like they sold the longstanding Infusion Business,(that was on the public record as growing and being profitable ) no doubt, as they were sailing close to receivership and had no option but a fire sale to keep the doors open and salaries secured.
From what I can tell ADAPT has also never turned a profit ?? Why ?? surely this lack of success must reflect on the value of the ADAPT technology
Looks like a whole series of very poor decisions by this management , underpinned by SP devaluation and overinflated salaries
My research tells me the critical variable in SP future value is the current management credibility
I imagine some of management could walk away now with fat bank accounts and this whole project would hold no accountability . Next
- Forums
- ASX - By Stock
- AVR
- Ann: Anti-calcification Comparison Study Interim Results
Ann: Anti-calcification Comparison Study Interim Results, page-72
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.78 |
Change
0.780(8.67%) |
Mkt cap ! $206.7M |
Open | High | Low | Value | Volume |
$9.00 | $9.83 | $8.68 | $324.0K | 35.80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 970 | $9.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.85 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 970 | 9.500 |
1 | 400 | 9.400 |
1 | 1000 | 9.000 |
1 | 650 | 8.980 |
1 | 1000 | 8.890 |
Price($) | Vol. | No. |
---|---|---|
9.850 | 1000 | 1 |
9.910 | 13 | 1 |
10.000 | 32000 | 2 |
10.200 | 545 | 1 |
11.500 | 250 | 1 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |